Literature DB >> 16098431

Impaired endothelial function in coronary heart disease patients with depressive symptomatology.

Andrew Sherwood1, Alan L Hinderliter, Lana L Watkins, Robert A Waugh, James A Blumenthal.   

Abstract

OBJECTIVES: The purpose of this study was to assess whether depressive symptomatology was associated with vascular endothelial dysfunction in patients with coronary heart disease (CHD).
BACKGROUND: In patients with CHD, the presence of depression is associated with a two to four times increased risk of mortality, but the disease pathways involved are uncertain. Endothelial dysfunction is an established risk factor for cardiovascular events in patients with CHD.
METHODS: Flow-mediated dilation (FMD) of the brachial artery, a measure of endothelial function, was assessed in 143 patients (99 men, 44 women), ages 40 to 84 years (mean age, 63 +/- 10 years), with documented CHD.
RESULTS: Patients with significant depressive symptomatology, as indicated by a Beck Depression Inventory (BDI) score > or = 10 (n = 47) showed attenuated FMD (p = 0.001) compared with patients that were not depressed (BDI < 10; n = 96). The use of antidepressant medication was associated with improved FMD (p < 0.05).
CONCLUSIONS: The increased risk of cardiovascular events in CHD patients with elevated symptoms of depression may be mediated, in part, by endothelial dysfunction.

Entities:  

Mesh:

Year:  2005        PMID: 16098431     DOI: 10.1016/j.jacc.2005.05.041

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  75 in total

Review 1.  Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma.

Authors:  Gilberto Paz-Filho; Julio Licinio; Ma-Li Wong
Journal:  Braz J Psychiatry       Date:  2010-06       Impact factor: 2.697

2.  Impact of daily lifestyle on coronary heart disease.

Authors:  Yan-Fang Wan; Xiao-Li Ma; Chen Yuan; Ling Fei; Jing Yang; Jun Zhang
Journal:  Exp Ther Med       Date:  2015-07-17       Impact factor: 2.447

Review 3.  Posttraumatic stress disorder, cardiovascular, and metabolic disease: a review of the evidence.

Authors:  Eric A Dedert; Patrick S Calhoun; Lana L Watkins; Andrew Sherwood; Jean C Beckham
Journal:  Ann Behav Med       Date:  2010-02

Review 4.  The impact of vascular burden on late-life depression.

Authors:  Micaela Santos; Enikö Kövari; Patrick R Hof; Gabriel Gold; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  Brain Res Rev       Date:  2009-09-08

Review 5.  Depressed mood and flow-mediated dilation: a systematic review and meta-analysis.

Authors:  Denise C Cooper; Lianne M Tomfohr; Milos S Milic; Loki Natarajan; Wayne A Bardwell; Michael G Ziegler; Joel E Dimsdale
Journal:  Psychosom Med       Date:  2011-06-02       Impact factor: 4.312

6.  Multiwave associations between depressive symptoms and endothelial function in adolescent and young adult females.

Authors:  Lianne M Tomfohr; Michael L M Murphy; Gregory E Miller; Eli Puterman
Journal:  Psychosom Med       Date:  2011-06-28       Impact factor: 4.312

Review 7.  Depression and Anxiety in Heart Failure: A Review.

Authors:  Christopher M Celano; Ana C Villegas; Ariana M Albanese; Hanna K Gaggin; Jeff C Huffman
Journal:  Harv Rev Psychiatry       Date:  2018 Jul/Aug       Impact factor: 3.732

8.  Coverage of blood vessels by astrocytic endfeet is reduced in major depressive disorder.

Authors:  Grazyna Rajkowska; Jonathan Hughes; Craig A Stockmeier; Jose Javier Miguel-Hidalgo; Dorota Maciag
Journal:  Biol Psychiatry       Date:  2012-11-10       Impact factor: 13.382

9.  The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes.

Authors:  Jeff C Huffman; Christopher M Celano; James L Januzzi
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

10.  Intima-media thickness and age of first depressive episode.

Authors:  Patrick J Smith; James A Blumenthal; Michael A Babyak; P Murali Doraiswamy; Alan Hinderliter; Benson M Hoffman; Robert Waugh; Andrew Sherwood
Journal:  Biol Psychol       Date:  2008-11-11       Impact factor: 3.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.